MINAPHARM Pharmaceuticals Sustainability Reports

Minapharm Pharmaceuticals and Chemical Industries S.A.E. specializes in developing, manufacturing, and marketing prescription pharmaceutical and biopharmaceutical products. Its product portfolio spans small-molecule medicines, vaccines, and cell and gene therapies targeting a variety of medical fields.

Sector: Manufacturing

Country: Egypt

Exchange: The Egyptian Exchange

FIGI: BBG001SPLB67

7 reports from 2022 to 2026

• MINAPHARM Pharmaceuticals 2026 Annual Report on Environmental, Social and Governance Disclosures Related to Sustainability (ESG)
• MINAPHARM Pharmaceuticals 2025 Independent Financial Statements and Auditor's Report
• MINAPHARM Pharmaceuticals 2024 Separate Financial Statements
• MINAPHARM Pharmaceuticals 2023 Independent Assurance Report on Compliance with Corporate Governance Rules
• MINAPHARM Pharmaceuticals 2023 Annual Climate-Related Financial Disclosures Report